Facebook
Twitter
LinkedIn
ForwardUpdates on Recently Authorized Therapies for COVID-19 Online CME Course
Recorded: April 28, 2021
This series of 90-minute webinars features Mayo Clinic experts discussing monoclonal antibodies and other novel therapeutics in COVID-19 treatment. Webinar recordings will be available within 48 hours.
On April 28th, 2021, Mayo Clinic experts reviewed recently authorized therapies for COVID-19, including monoclonal antibody treatment and other novel therapeutics.
Please "Register" to view the video and claim up to 1.50 CME credits at no cost.
The views and perspectives shared in these resources are presented based on information available at the time of recording.
Target Audience
Healthcare workers of all specialties who are being impacted by COVID-19, including physicians, research scientists, physician assistants, nurse practitioners, nurses, and anyone with a particular interest in prevention, treatment, and patient care.
Learning Objectives
Upon completion of this activity, you will be able to:
- Explain the effect of neutralizing viral monoclonal bodies on the SARS-COV2 virus
- Explain how mAb fit in the current paradigm of outpatient medical therapy of COVID-19
- Explain contraindications for mAb and how to manage reactions and complications from mAb
Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.
COMMERCIAL SUPPORT
This educational activity is supported in part by an
independent medical education grant from
Eli Lilly and Company
and is in accordance with ACCME guidelines.
Additional Information
| Attachment | Size |
|---|---|
 Additional Information and Faculty Disclosures | 132.78 KB |
 | Course Director Devyani Lal, M.D. Associate Dean, Mayo Clinic School of Continuous Professional Development Professor of Otolaryngology, College of Medicine Chair, Division of Rhinology Mayo Clinic in Arizona |
 | Moderator |
Featured Experts:
 | Lori L. Arndt, P.A.-C. Division of Infectious Diseases Mayo Clinic Health Systems in Eau Claire, Wisconsin |  | Richard Arndt, Pharm.D., R.Ph. Assistant Professor of Pharmacy, College of Medicine Mayo Clinic Health Systems in Eau Claire, Wisconsin |
 | Ravindra Ganesh, M.B.B.S., M.D. Assistant Professor of Medicine, College of Medicine Consultant, General Internal Medicine Executive and International Medicine Mayo Clinic in Minnesota |  | Larry Lutwick, M.D. |
 | Raymund R. Razonable, M.D. Professor of Medicine, College of Medicine Consultant, Infectious Diseases Mayo Clinic in Minnesota |
Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Statements:
AMA
Mayo Clinic College of Medicine and Science designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ANCC
Mayo Clinic College of Medicine and Science designates this enduring material for a maximum of 1.50 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
AOA
The American Osteopathic Association designates this program for a maximum of 1.50 AOA Category 2-A credits.
Other Healthcare Professionals
A record of attendance will be provided to all registrants for requesting credits in accordance with state nursing boards, specialty societies or other professional associations.
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.
Available Credit
- 1.50 AMA PRA Category 1 Credit™
- 1.50 ANCC
- 1.50 AOA Category 2-A
- 1.50 Attendance
Price
Access to online streaming course is available from the date of purchase until the course expires on April 28, 2023. Credit must be claimed within that time period.
If you attended and claimed CME credit for the Live Webinar on April 28th, you are unable to access the Online CME course.
Any use of this site constitutes your agreement to the Terms and Conditions of Registration.